Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone in Postpartum Depression (Amaryllis)
NCT03460756Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in postpartum depression (PPD), sponsored by Marinus Pharmaceuticals. Started Dec 2017; status: completed.
02
Drugs
ganaxolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT03460756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03460756.